Skip to main content
NCBI home page
Cellular and Molecular Neurobiology logoLink to Cellular and Molecular Neurobiology
. 2002 Dec;22(5-6):783–795. doi: 10.1023/A:1021817326632

Role of Endothelin Type B Receptor in NO/cGMP Signaling Pathway in Rat Median Eminence

Yaira Mathison 1, Anita Israel 2
PMCID: PMC11533767  PMID: 12585695

Abstract

We studied the effect of endothelins (ETs) on receptor-mediated NO/cGMP signaling in rat arcuate nucleus–median eminence (AN-ME) fragments, an hypothalamic structure known to contain a rich plexus of nitric oxide synthase (NOS)-containing neurons and fibers together with densely arranged ETB-receptor-like immunoreactive fibers. NOS activity was determined measuring the conversion of [3H] arginine to [3H] citrulline, as an index of NO produced. cGMP production was determined by radio immunoassay. ET-1, ET-3, and the selective ETB receptor agonist, IRL1620, significantly increased cGMP formation and NOS activity. Preincubation of AN-ME fragment with L-arginine analog, N-nitro-L-arginine (L-NAME), inhibited ET-1 or IRL1620-stimulated cGMP formation. The addition of the selective ETB receptor antagonist, BQ788, blocked ET-1-, ET-3-, or IRL1620-induced increase in NOS activity and cGMP generation, while BQ123, a selective ETA receptor antagonist, was ineffective. Our results demonstrate that in whole rat AN-ME fragments, ETs stimulate NO/cGMP signaling pathway through the interaction with the ETB receptor subtype, supporting the concept that ETs may represent an important regulator of reproductive and neuroendocrine function.

Keywords: nitric oxide, cGMP, endothelin, ETB receptor, median eminence

REFERENCES

  1. Arai, H., Hori, S., Aramori, I., Ohkubo, H., and Nakanishi, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature348:730–732. [DOI] [PubMed] [Google Scholar]
  2. Brann, D. W., Bhat, G. K., Lamar, C. A., and Mahesh, V. B. (1997). Gaseous transmitters and neuroendocrine regulation. Neuroendocrinology65:385–395. [DOI] [PubMed] [Google Scholar]
  3. Bredt, D. S., Glatt, C. E., Hwang, P. M., Fotuhi, M., Dawson, T. M., and Snyder, S. H. (1991). Nitric oxide synthase protein and mRNAare discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron7:615–624. [DOI] [PubMed] [Google Scholar]
  4. Bredt, D. S., and Snyder, S.H. (1990). Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A.87: 682–685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calogero, A. E., Raiti, F., Nicolosi, G., Burrello, N., D'Agata, R. D., and Matero, F. (1994). Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticothophin-releasing hormone and pituitary ACTH release in vitro. J. Endocrinol.140:419–424. [DOI] [PubMed] [Google Scholar]
  6. Costa, A., Trainer, R., Besser, M., and Grossman, A. (1993). Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res.605:187–192. [DOI] [PubMed] [Google Scholar]
  7. D'Amico, M., Di Fillipo, C., and Rossi, F. (1998). Depresor response to endothelin into the superior colliculus of rats: Predominant role of endothelin ETB receptor. Eur. J. Pharmacol. 347:71–75. [DOI] [PubMed] [Google Scholar]
  8. De Vente, J., Hopkins, D. A., Markerink-Van Ittersum, M., Emson, P. C., Schmidt, H. H. H. W., and Steinbusch, H. W. M. (1998). Distribution of nitric oxide synthase and nitric oxide-receptive cyclic GMP-producing structures in the rat brain. Neuroscience87:207–241. [DOI] [PubMed] [Google Scholar]
  9. Dinerman, L., Dawson, T. M., Schell, M. J., Snowman, A., and Snyder, S. H. (1994). Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A.91:4214–4218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Di Nuncio, A. S., Jaureguiberry, M. S., Rodano, V., Bianciotti, L. G., and Vatta, M. S. (2002). Endothelin-1 and-3 diminish neuronal NE release through an NO mechanism in rat anterior hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol.283:R615–R622. [DOI] [PubMed] [Google Scholar]
  11. Edwards, R. M., Pullen, M., and Nambi, P. (1992). Activation of endothelin ETB receptors increases glomerular cGMP via an L-arginine-dependent pathway. Am. J. Physiol.263:F1020–F1025. [DOI] [PubMed] [Google Scholar]
  12. Evans, J. J. (1999). Modulation of gonadotrophin levels by peptides acting at the anterior pituitary gland. Endocrinol. Rev. 20:46–67. [DOI] [PubMed] [Google Scholar]
  13. Fujitani, Y., Udea, H., Okada, T., Urade, Y., and Karaki, H. (1993). A selective agonist of endothelin type B receptor, IRL1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta. J. Pharmacol. Exp. Ther.267:683–689. [PubMed] [Google Scholar]
  14. Giaid, A., Gibson, S. J., Herrero, M. T., Gentleman, S., Legon, S., Yanagisawa, M., Masaki, T., Ibrahim, N. B. N., Roberts, G.W., Rossi, M. L., and Polak, J. M. (1991). Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry95:303–314. [DOI] [PubMed] [Google Scholar]
  15. Hagiwara, H., Nagasawa, T., Yamamoto, T., Lodhi, K. M., Ito, T., Takemura, N., and Hirose, S. (1993). Immunochemical characterization and localization of endothelin ETB receptor. Am. J. Physiol. 264:R777–R783. [DOI] [PubMed] [Google Scholar]
  16. Herbison, A. E., Simonian, S. X., Norris, P. J., and Emson, P. C. (1996). Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat. J. Neuroendocrinol.8:73–82. [DOI] [PubMed] [Google Scholar]
  17. Hirata, Y., Emori, T., Eguchi, S., Kanno, K., Imai, T., Ohta, K., and Marumo, F. (1993). Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J. Clin. Invest.91:1367–1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hori, S.,Komatsu,Y., Shigemoto, R., Mizuno, M., and Nakanishi, S. (1992). Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology130:1885–1895. [DOI] [PubMed] [Google Scholar]
  19. Ishii, K., Warner, T. D., Sheng, H., and Murad, F. (1991). Endothelin increases cyclic GMP levels in LLCPK1 porcine kidney epithelial cells via formation of an endothelium-derived relaxing factor-like substance. J. Pharmacol. Exp. Ther. 259:1102–1108. [PubMed] [Google Scholar]
  20. Israel, A., Garrido, M. R., Mathison, Y., Barbella, Y., and Becemberg, I. (1990). Brain Natriuretic Peptide stimulates particulate guanylate cyclase activity in selected areas of the rat brain. Neurosci. Lett.114(1)114:107–112. [DOI] [PubMed] [Google Scholar]
  21. Kadekaro, M., Terrell, M. L., Liu, H., Gestl, S., Bui, V., and Summy-Long, J. Y. (1998). Effect of L-NAME on cerebral metabolic, vasopressin, oxytocin, and blood pressure responses in haemorrhaged rats. Am. J. Physiol.274:R1070–R1077. [DOI] [PubMed] [Google Scholar]
  22. Kawakami, S., Ichikawa, M., Yokosuka, M., Tsukamura, H., and Maeda, K. (1998). Glial and neuronal localization of neuronal nitric oxide synthase immunoreactivity in the median eminence of female rats. Brain Res. 789:322–326. [DOI] [PubMed] [Google Scholar]
  23. Kawano, Y., Yoshida, K., Yoshimi, H., Kuramochi, M., and Omae, T. (1989). The cardiovascular effect of intracerebroventricular endothelin in rats. J. Hypertens.7(Suppl.):S22–S23. [DOI] [PubMed] [Google Scholar]
  24. Knowles, R. G., Palacios, M., Palmer, R. M. J., and Moncada, S. (1989). Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimualtion of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A.86:5159–5162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kohzuki, M., Chai, S. Y., Paxinos, G., Karavas, A., Casley D. J., Johnston, C. I., and Mendelshon, F. A. O. (1991). Localization and characterization of endothelin binding sites in the rat brain visualized by in vitro autoradiography. Neuroscience42:245–260. [DOI] [PubMed] [Google Scholar]
  26. Kurokawa, K., Yamada, H., Liu, Y., and Kudo, M. (2000). Immunohistochemical distribution of the endothelin-converting enzyme-1 in the rat hypothalamo-pituitary axis. Neurosci. Lett. 284(1/2):81–84. [DOI] [PubMed] [Google Scholar]
  27. Kurokawa, K., Yamada, H., and Ochi, J. (1997). Topographical distribution of neurons containing endothelin type A receptor in the rat brain. J. Comp. Neurol. 389:348–360. [DOI] [PubMed] [Google Scholar]
  28. Lopez, F. J., Moretto, M., Merchenthaler, I., and Negro-Vilar, A. (1997). Nitric oxide is involved in the genesis of pulsatile LHRH secretion from immortalized LHRH neurons. J. Neuroendocrinol. 9:647–654. [DOI] [PubMed] [Google Scholar]
  29. Lowry, O., Rosebrough, N., Farr, A., and Randall, R. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem.193:265–275. [PubMed] [Google Scholar]
  30. Mathison, Y., and Israel, A. (1998). Endothelin ETB receptor subtype mediates nitric/oxide cGMP formation in rat adrenal medulla. Brain Res. Bull. 45:15–19. [DOI] [PubMed] [Google Scholar]
  31. McCumber, M.W., Ross, C. A., and Snyder, S.H. (1990). Endothelin in brain: Receptors, mitogenesis and biosynthesis in glial cells. Proc. Natl. Acad. Sci. U.S.A.87:2358–2363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Moretto, M., Lopez, F.J., and Negro-Vilar, A. (1993a) Endothelin-3 stimulates luteinizing hormonereleasing hormone (LHRH) secretion from LHRH neurons by a prostaglandin-dependent mechanism. Endocrinology132:789–794. [DOI] [PubMed] [Google Scholar]
  33. Moretto, M., Lopez, F. J., and Negro-Vilar, A. (1993b). Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology133:2399–2402. [DOI] [PubMed] [Google Scholar]
  34. Moritoki, H., Miyano, H., Takeuchi, S., Yamaguchi, M., Hisayama,T., and Kondoch,W. (1993). Endothelin-3-induced relaxation of rat thoracic aorta: A role for nitric oxide formation. Br. J. Pharmacol. 108:1125–1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mosqueda-García, R., Fernandez-Violante, R., Hamakibo, T., and Stainback R. (1996). Vasopressin mediates the pressor effects of endothelin in the subfornical organ of the rat. J. Pharmacol. Exper. Ther.277:1034–1042. [PubMed] [Google Scholar]
  36. Mosqueda-García, R., Inagami, T., Appalsemy, M., Sugiura, M., and Robertson, R. M. (1993). Endothelin as a neuropeptide cardiovascular effects in the brainstem of normotensive rats. Circ. Res. 72:20–35. [DOI] [PubMed] [Google Scholar]
  37. Mosqueda-García, R., Yates, K., O'Leary, J., and Inagami, T. (1995). Cardiovascular and respiratory effect of endothelin in the ventrolateral medulla of normotensive rat. Hypertension26:263–271. [DOI] [PubMed] [Google Scholar]
  38. Owada, A., Tomita, K., Terada, Y., Sakamoto, H., Nonoguchi, H., and Marumo, F. (1994). Endothelin (ET)-3 stimulates cyclic guanosine 30, 50-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells. J. Clin. Invest. 93:556–563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Prevot,V., Bouret, S., Stefabo, G. B., and Beauvillan, J.-C. (2000). Median eminence nitric oxide signalling. Brain Res. Rev.34:21–41. [DOI] [PubMed] [Google Scholar]
  40. Rettori, V., Belova, N., Dees, W. L., Nyberg, C. L., Gimeno, M., and McCann, S. M. (1993). Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A.90:10130–10134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sakurai, T., Yanagisawa, M., Takura,Y., Miyazaki, H., Kimura, S., Goto, K., and Masaki, T. (1990). Cloning of a cDNAencoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (London)348:732–735. [DOI] [PubMed] [Google Scholar]
  42. Samson, W. K., Skala, K. D., Alexander, B. D., and Huang, F. L. S. (1991a). Possible neuroendocrine actions of endothelin-3. Endocrinology128:1465–1473. [DOI] [PubMed] [Google Scholar]
  43. Samson, W. K., Skala, K. D., Alexander, B. D., and Huang, F. L. S. (1991b). Hypothalamic endothelin: Presence and effects related to fluid and electrolyte homeostasis. J. Cardiovasc. Pharmacol. 17:S346–S349. [PubMed] [Google Scholar]
  44. Schuman, E. M., and Madison, D. V. (1994). Nitric oxide and synaptic function. Annu. Rev. Neurosci.17:153–183. [DOI] [PubMed] [Google Scholar]
  45. Seidel, B., Stanarius, A., and Wolf, G. (1997). Differential expression of neuronal and endothelial nitric oxide synthase in blood vessels of the rat brain. Neurosci. Lett. 239:109–112. [DOI] [PubMed] [Google Scholar]
  46. Sluck, J. M., Lin, R. C. S., Katolik, L. I., Jeng, A. Y., and Lehmann, J. C. (1999). Endothelin converting enzime-1, endothelin-1 and endothelin-3 like immunoreactivity in the rat brain. Neuroscience91:1483–1497. [DOI] [PubMed] [Google Scholar]
  47. Snyder, S. H., and Bredt, D. (1991). Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci.12:125–128. [DOI] [PubMed] [Google Scholar]
  48. Stanarius, A., Topel, I., Schulz, S., Noack, H., and Wolf, G. (1997). Immunocytochemistry of endothelial nitric oxide synthase in the rat brain: A light and electron microscopical study using the tyramide de signal amplification technique. Acta Histochem. 99:411–429. [DOI] [PubMed] [Google Scholar]
  49. Steiner, A., Parker, C., and Kipnis, D.M. (1972). Radio-immunoassay for cyclic nucleotides. J. Biol. Chem.247:1106–1113. [PubMed] [Google Scholar]
  50. Szabó, C. (1996) Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull.41:131–141. [DOI] [PubMed] [Google Scholar]
  51. Tadepalli, A. S., and Hashim, M. A. (1995). Mechanisms of central endothelin-induced hypotension. Naunyn Schmiedebergs Arch. Pharmacol.352:108–112. [DOI] [PubMed] [Google Scholar]
  52. Takai, M., Umemura, I., Yamasaki, K., Waranabe, T., Fujitani,Y., Oda, K., Urade,Y., Unui, T., Yamamura, T., and Okada, T. (1992). A potent and specific agonist, Suc-(Glu9, Ala11,15)-endothelin-1(18-21), IRL-1620, for ETB receptor. Biochem. Biophys. Res. Commun. 184:953–959. [DOI] [PubMed] [Google Scholar]
  53. Wall, K. M., and Ferguson, A. V. (1992). Brain Res.586:111–116. [DOI] [PubMed] [Google Scholar]
  54. Yamada, K., Emson, P., and Hokfelt, T. (1996) Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides. J. Chem. Neuroanat.10:295–316. [DOI] [PubMed] [Google Scholar]
  55. Yamada, H., and Kurokawa, K. (1998). Histochemical studies on endothelin and endothelin-A receptor in the hypothalamus. J. Cardiovasc. Pharmacol. 311(Suppl. 1):215–218. [DOI] [PubMed] [Google Scholar]
  56. Yamamoto, T., Suzuki, H., and Uemura, H. (1997). Endothelin B receptor-like immunoreactivity is associated with LHRH-immunoreactive fibers in the rat hypothalamus. Neurosci. Lett.223:117–120. [DOI] [PubMed] [Google Scholar]
  57. Yamamoto, T., and Uemura, H. (1998). Distribution of endothelin B receptor-like immunoreactivity in the rat brain, kidney, and pancreas. J. Cardiovasc. Pharmacol.311(Suppl. 1):S207–S211. [DOI] [PubMed] [Google Scholar]
  58. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Goto, K., and Masaki, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature332:411–415. [DOI] [PubMed] [Google Scholar]

Articles from Cellular and Molecular Neurobiology are provided here courtesy of Springer

RESOURCES